A recent study investigated the transcriptional activity of the herpes simplex virus 1 (HSV-1) in human neurons, revealing surprising insights into viral latency. Using precision…
Recent research reveals that M1 macrophages are crucial for developing trained immunity in response to HSV-1 infection, highlighting their role in antiviral defense. This study ut…
The FDA has granted accelerated approval to Tudriqev, a new engineered viral immunotherapy for patients with treatment-resistant advanced melanoma. This therapy, used in combinati…